PDF (Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
833kB | |
PDF (Additional file)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
5kB |
Item Type: | Article |
---|---|
Title: | Concerted down-regulation of immune-system related genes predicts metastasis in colorectal carcinoma |
Creators Name: | Fehlker, M., Huska, M.R., Joens, T., Andrade-Navarro, M.A. and Kemmner, W. |
Abstract: | BACKGROUND: This study aimed at the identification of prognostic gene expression markers in early primary colorectal carcinomas without metastasis at the time point of surgery by analyzing genome-wide gene expression profiles using oligonucleotide microarrays. METHODS: Cryo-conserved tumor specimens from 45 patients with early colorectal cancers were examined, with the majority of them being UICC stage II or earlier and with a follow-up time of 41-115 months. Gene expression profiling was performed using Whole Human Genome 4x44K Oligonucleotide Microarrays. Validation of microarray data was performed on five of the genes in a smaller cohort. RESULTS: Using a novel algorithm based on the recursive application of support vector machines (SVMs), we selected a signature of 44 probes that discriminated between patients developing later metastasis and patients with a good prognosis. Interestingly, almost half of the genes was related to the patients' immune response and showed reduced expression in the metastatic cases. CONCLUSIONS: Whereas up to now gene signatures containing genes with various biological functions have been described for prediction of metastasis in CRC, in this study metastasis could be well predicted by a set of gene expression markers consisting exclusively of genes related to the MHC class II complex involved in immune response. Thus, our data emphasize that the proper function of a comprehensive network of immune response genes is of vital importance for the survival of colorectal cancer patients. |
Keywords: | Early Colorectal Cancer, Metastasis, Computational Marker Analysis, Immune System, Gene Expression Profiling |
Source: | BMC Cancer |
ISSN: | 1471-2407 |
Publisher: | BioMed Central |
Volume: | 14 |
Number: | 1 |
Page Range: | 64 |
Date: | 5 February 2014 |
Official Publication: | https://doi.org/10.1186/1471-2407-14-64 |
PubMed: | View item in PubMed |
Repository Staff Only: item control page